Ahead of GTA 6, Zelnick told Business Insider he skips untested peptides and leans on sleep, walking and not smoking. He also took a shot at David Sinclair.
Recap by typeshit. Full story at Business Insider.
The 52-year-old actor points to his early 4am workouts and discipline instead of weight loss shots. A celebrity opinion, not new data.
Metz says the drug improved her mobility enough to handle eight Broadway shows a week in "& Juliet". Her account, not a clinical claim.
A general piece on how GLP-1 drugs like Ozempic and Wegovy reshaped weight management in the US. Light on new details.
The broker says Laurus beat 2QFY27 estimates on EBITDA and profit, with its CDMO pipeline and peptide work driving the higher forecasts.
Yaccarino argues the drugs help employers' bottom line as well as waistlines. It's an opinion post, with no data attached to back the claim.
Part of his GLP-1 series, Krittanawong discusses whether the drugs could help MASLD and MASH, and how visceral fat can drive metabolic problems unseen.
Loading…